Form 4: Somu Subramaniam Reports Changes in Beneficial Ownership of Ventyx Biosciences
SEC Form 4 Filing
Director Somu Subramaniam reports a distribution of Ventyx Biosciences shares from NSV Investments I, L.P. to its limited partners.
Summary
- On March 10, 2025, Somu Subramaniam, a director of Ventyx Biosciences, reported a transaction involving the company's common stock.
- NSV Investments I, L.P. distributed 1,735,306 shares to its limited partners on a pro rata basis for no consideration.
- Following the transaction, Subramaniam directly owns 0 shares and indirectly owns 5,367,663 shares.
- The indirect ownership is through various entities including NSV Partners III, L.P., New Science Ventures, LLC, and NSV Partners II, LLC.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, so the sentiment is neutral.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders.
Stakeholder Impact
- Shareholders are informed about changes in insider ownership.
- The filing ensures transparency and compliance with SEC regulations.
Key Dates
| Date | Description |
|---|---|
| 03/10/2025 | Date of the share distribution transaction. |
| 03/12/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.